טוען...
Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
Metastatic triple-negative breast cancer (TNBC) is a heterogeneous disease with a poor prognosis and currently with few treatment options. Treatment of these patients is highly based on systemic chemotherapy. Some targeted drugs were recently approved for these patients: two poly(ADP-ribose) polymer...
שמור ב:
| הוצא לאור ב: | Breast Cancer (Auckl) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989121/ https://ncbi.nlm.nih.gov/pubmed/33814914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/11782234211002491 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|